Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
iOThree Limited Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency
-
The Children’s Place Reports First Quarter 2025 Results
-
Core Silver Amends Terms of Non-Brokered Private Placement Offering
-
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
-
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Franchise Group Successfully Completes Financial Restructuring
-
Bret Talley Scholarship and Talley Digital Media Announce 2025 Winner
-
CareRx Reports Voting Results from Annual General Meeting of Shareholders
-
LAZYDAYS AND GENERAL RV COMPLETE FT. PIERCE, FLORIDA TRANSACTION
-
Broadway Technology Inc Announces Entering into a Merger Agreement with Quartzsea Acquisition Corporation
-
Genpact Limited Board Declares Quarterly Cash Dividend
-
DICK'S Sporting Goods Commences Exchange Offer and Consent Solicitation for Foot Locker's Senior Notes Due 2029
-
Magnetic North Acquisition Corp. Provides Bi-Weekly Update On Status Of Management Cease Trade Order
-
indie Semiconductor Announces New Employee Inducement Grants
-
Wedding Expert Jessica Bishop to Host Free Virtual Savvy Weddings Summit
-
Opendoor Announces Preliminary Proxy Filing Seeking Approval for Discretionary Reverse Stock Split
-
SRQ Resources Announces Results of AGM
-
Playa Hotels & Resorts N.V. Announces Mexican Antitrust Approval of Pending Sale to Hyatt and Intent to Voluntarily Delist from the Nasdaq Subject to and Conditioned Upon the Expiration of the Ten
-
Hyatt Announces Receipt of All Required Regulatory Approvals for Pending Acquisition of Playa Hotels & Resorts N.V.
-
XcelLabs Launches To Transform Accounting
-
Rakovina Therapeutics Announces the Closing of Oversubscribed Private Placement of $4.9 Million
-
RESTEM to Present Phase 2/3 IIMPACT Trial Design in Idiopathic Inflammatory Myopathy at EULAR 2025 Congress
-
Smith & Wesson Brands, Inc. Announces Rescheduling of Fourth Quarter and Full Fiscal 2025 Financial Release and Conference Call
-
Kennametal Announces Sale of Subsidiary in Goshen, IN
-
Spyre Therapeutics Announces Grants of Inducement Awards
-
Skillsoft Announces New Employee Inducement Grant Under NYSE Rule 303A.08
-
Enovis to Participate in Upcoming Investor Conferences
-
BloomZ Granted 180 Day Extension by Nasdaq to Regain Compliance with Minimum Bid Requirement
-
Globalink Investment Inc. Announces Extension of the Deadline to Complete a Business Combination to July 9, 2025
-
PolyPid to Host Conference Call and Webcast to Discuss D-PLEX₁₀₀ SHIELD II Phase 3 Trial Topline Results on Monday, June 9, 2025
-
89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
TELA Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
-
Canadian Securities Exchange Welcomes Listing of Aleen Inc
-
BRMK INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Broadmark Realty Capital Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
-
FTRE INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Fortrea Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
-
URGN INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that UroGen Pharma Ltd. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
-
OGN INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Organon & Co. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
-
DMRC INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Digimarc Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
-
WST INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that West Pharmaceutical Services, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
-
Arcos Dorados Announces Management Changes
-
Keros Therapeutics Announces Participation at Goldman Sachs 46th Annual Global Healthcare Conference
-
Neurogene Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Replimune Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Greenberg Traurig Adds Private Funds Attorney Daniel F. Rayner to Corporate Practice in New York
-
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Shift4 Announces Upcoming Investor Conference Participation
-
InvestorNewsBreaks – Newton Golf Company Inc. (NASDAQ: NWTG) Leads with Vision and Cutting-Edge Gear Amid Golf’s Resurgence
-
Northann Corp. Issues Statement on Recent Stock Volatility
-
Parvis Closes First Tranche of Convertible Debenture Financing and Finalizes Strategic Appointments
-
NIRI Florida Announces its 2025-2026 Board of Directors
